These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9776809)

  • 1. Analysis of fluconazole effect on Candida albicans viability during extended incubations.
    Sohnle PG; Hahn BL; Fassel TA; Kushnaryov VM
    Med Mycol; 1998 Feb; 36(1):29-36. PubMed ID: 9776809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of fluconazole on viability of Candida albicans over extended periods of time.
    Sohnle PG; Hahn BL; Erdmann MD
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2622-5. PubMed ID: 8913476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
    De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
    J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal activity of azole compounds CPA18 and CPA109 against azole-susceptible and -resistant strains of Candida albicans.
    Calabrese EC; Castellano S; Santoriello M; Sgherri C; Quartacci MF; Calucci L; Warrilow AG; Lamb DC; Kelly SL; Milite C; Granata I; Sbardella G; Stefancich G; Maresca B; Porta A
    J Antimicrob Chemother; 2013 May; 68(5):1111-9. PubMed ID: 23292344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The value of the agar dilution method as a screening test for determining the sensitivity of Candida albicans to fluconazole].
    Yücesoy M; Marol S
    Mikrobiyol Bul; 2002; 36(3-4):317-22. PubMed ID: 12838666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of human serum on antifungal pharmacodynamics with Candida albicans.
    Zhanel GG; Saunders DG; Hoban DJ; Karlowsky JA
    Antimicrob Agents Chemother; 2001 Jul; 45(7):2018-22. PubMed ID: 11408217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fungicidal effect of photodynamic therapy against fluconazole-resistant Candida albicans and Candida glabrata.
    Dovigo LN; Pavarina AC; Mima EG; Giampaolo ET; Vergani CE; Bagnato VS
    Mycoses; 2011 Mar; 54(2):123-30. PubMed ID: 19889173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biofilm formation by fluconazole-resistant Candida albicans strains is inhibited by fluconazole.
    Bruzual I; Riggle P; Hadley S; Kumamoto CA
    J Antimicrob Chemother; 2007 Mar; 59(3):441-50. PubMed ID: 17261564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The combination of minocycline and fluconazole causes synergistic growth inhibition against Candida albicans: an in vitro interaction of antifungal and antibacterial agents.
    Shi W; Chen Z; Chen X; Cao L; Liu P; Sun S
    FEMS Yeast Res; 2010 Nov; 10(7):885-93. PubMed ID: 20707818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the order of initiation of fluconazole and amphotericin B in sequential or combination therapy on killing of Candida albicans in vitro and in a rabbit model of endocarditis and pyelonephritis.
    Louie A; Kaw P; Banerjee P; Liu W; Chen G; Miller MH
    Antimicrob Agents Chemother; 2001 Feb; 45(2):485-94. PubMed ID: 11158745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of fluconazole on Candida albicans.
    Abecia LC; Arévalo JM; López MJ
    Microbiologia; 1996 Dec; 12(4):613-20. PubMed ID: 9018696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Terpenoids inhibit Candida albicans growth by affecting membrane integrity and arrest of cell cycle.
    Zore GB; Thakre AD; Jadhav S; Karuppayil SM
    Phytomedicine; 2011 Oct; 18(13):1181-90. PubMed ID: 21596542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent antifungal activity of extracts and pure compound isolated from pomegranate peels and synergism with fluconazole against Candida albicans.
    Endo EH; Cortez DA; Ueda-Nakamura T; Nakamura CV; Dias Filho BP
    Res Microbiol; 2010 Sep; 161(7):534-40. PubMed ID: 20541606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subinhibitory concentrations of fluconazole increase the intracellular sodium content in both fluconazole-resistant and -sensitive Candida albicans strains.
    Kolecka A; Krauke Y; Bujdakova H; Sychrova H
    Can J Microbiol; 2009 May; 55(5):605-10. PubMed ID: 19483789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on experimental induction of fluconazole resistance in Candida albicans].
    Zhu YN; Lu SM
    Shi Yan Sheng Wu Xue Bao; 2004 Oct; 37(5):418-22. PubMed ID: 15636370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility and trailing growth of Candida albicans to fluconazole: results of a Korean multicentre study.
    Lee MK; Kim HR; Kang JO; Kim MN; Kim EC; Kim JS; Kim JJ; Park YJ; Song W; Shin JH; Lee KM; Lee NY; Lee M; Lee WG; Lee CK; Lee HJ; Chang CL; Choi TY
    Mycoses; 2007 Mar; 50(2):148-9. PubMed ID: 17305780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic antifungal effect of lactoferrin with azole antifungals against Candida albicans and a proposal for a new treatment method for invasive candidiasis.
    Kobayashi T; Kakeya H; Miyazaki T; Izumikawa K; Yanagihara K; Ohno H; Yamamoto Y; Tashiro T; Kohno S
    Jpn J Infect Dis; 2011; 64(4):292-6. PubMed ID: 21788703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro synergy of pseudolaric acid B and fluconazole against clinical isolates of Candida albicans.
    Guo N; Ling G; Liang X; Jin J; Fan J; Qiu J; Song Y; Huang N; Wu X; Wang X; Deng X; Deng X; Yu L
    Mycoses; 2011 Sep; 54(5):e400-6. PubMed ID: 21910756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of the transcriptional regulator Cas5 results in enhanced killing of Candida albicans by Fluconazole.
    Vasicek EM; Berkow EL; Bruno VM; Mitchell AP; Wiederhold NP; Barker KS; Rogers PD
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6807-18. PubMed ID: 25182640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The alternative oxidase of Candida albicans causes reduced fluconazole susceptibility.
    Yan L; Li M; Cao Y; Gao P; Cao Y; Wang Y; Jiang Y
    J Antimicrob Chemother; 2009 Oct; 64(4):764-73. PubMed ID: 19656781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.